While pharmaceutical innovation has improved the quality of life, there remains a wide range of challenges facing the industry. The Rutgers Mini-MBA™: BioPharma Innovation program explores new business models and the vision required to address these challenges. Learning is focused on building business skills tailored to the needs of the Biotech and Pharmaceutical industries, while challenging participants to consider new business paradigms promoting sustainable revenue growth, stakeholder cooperation, and cost management in a capstone session.
Format:
Twelve 3-hour modules. Must attend a Minimum of 10 sessions to earn a certificate.
This program has been approved by the New Jersey Department of Labor for workforce training grants. Funding may be available for those receiving unemployment benefits. Contact us for more information.
The Mini-MBA™: BioPharma Innovation is a certificate program for:
- Science or business professionals in the biotech or pharmaceutical industries desiring to enhance their business acumen and improve their ability to work across functions in their organizations
- Company teams or cross-functional groups who are seeking to leverage the value of new learning tools and resources throughout the organization
- Leaders who have been promoted into commercial roles from functional, medical, chemical or engineering backgrounds
- Senior Scientists making the transition into management positions
- Students pursuing advanced study and contemplating careers in the bioscience sector (MD, PhD)
This program provides participants with an understanding of:
- A new vision for pharmaceutical business modeling based on cooperation between healthcare stakeholders and patient outcomes
- How strategies for the discovery, analysis and approval of new drugs are developed
- Intellectual property laws and government policies driving drug development decisions
- The clinical/regulatory process and timelines at the US FDA and its foreign counterparts
- How potential therapeutic areas for pharmaceutical intervention are identified, researched and analyzed
- How to construct written/oral reports for drug development and marketing
After completing the program, participants will be familiar with how key functions work together to develop a successful drug, as well as how researching, modeling, and projecting market opportunities for specific therapeutic areas create future market opportunities.
The Rutgers Mini-MBA™: BioPharma Innovation features focused learning experiences and case studies on vital subject areas in today’s rapidly changing industry environment. Twelve sessions are delivered in three-hour modules. To see a detailed description of the program, please download the program brochure.Topics may include:
Strategy And Context
- Globalization & Innovation: New Technologies, New Talent, Successful Strategies & Future Challenges
- The Economic Policy Context
- Innovation in the BioPharma Industry
- The FDA & the Regulatory Process
- Understanding the Marketplace: Evolving Healthcare Systems in the US & Abroad
Financial Analysis
- Analysis of Financial Statements
- Modeling the ROI in R&D
- Portfolio Strategy & Management
Alliances And Interfirm Relationships
- Supply Chain Development
- Strategic Alliances & Acquisitions
- Technology Management & Licensing
- Intellectual Property
Marketing And Pricing
- Market Research & Financial Drivers
- Marketing Management
- Pharmacoeconomics, Pricing & Reimbursement in Healthcare
Strategy Implementation
- Business Ethics & Social Responsibility in the BioScience Industry
- Managing Strategic Transformations to Meet Stakeholder Needs
- Designing Effective Organizations
Capstone Session
- Business Analysis of Future Business Models: Problem Solving with Interdisciplinary Teams
